EASD data showed Lilly's EloraTZP combo cut 23% of body weight. Zealand's petrelintide trial lead says nausea ran at under half the usual GLP-1 rate.
Recap by typeshit. Full story at greatergood.
Popular Mechanics traces how her 1980s work at Mass General showed GLP-1 triggers insulin release. Gallup now puts GLP-1 weight loss use at about 11% of Americans.
Barzilai highlights trial results on retatrutide in adults with sleep apnea and obesity or overweight, a new use being tested for Lilly's drug.
The Washington meeting runs November 14 to 17, with primary REDEFINE 9 results and pediatric semaglutide research for kids 6 to under 12.
Researchers tracked spending on drinks while out and found a sharp drop among people taking GLP-1 medications.
Ahead of GTA 6, Zelnick told Business Insider he skips untested peptides and leans on sleep, walking and not smoking. He also took a shot at David Sinclair.
Coroner David Ryan found Norton had been taking double his prescribed dose and urged Australia's TGA to tighten rules on peptides, limiting them to clinical trials.
Loading…